经皮经胸穿刺活检（TTNB）和肺肿瘤消融的临床作用和使用正在发展。在这里，我们讨论推荐提供者的重要考虑因素，包括指南支持的当前和新出现的适应症，术前和术后患者管理的关键方面，和预期的术后影像学发现。
The clinical role and use of percutaneous transthoracic needle biopsy (TTNB) and ablation of lung tumors are evolving. Here we discuss important considerations for referring providers, including current and emerging indications supported by guidelines, critical aspects of pre and postprocedure patient management, and expected postprocedure imaging findings.
